FOI release

Study WIL-353039, Beck, And September 2004 - Prozac

Some or all of the information requested was not provided because we determined that the cost to do so would exceed the appropriate limit.

Case reference FOI2026/00129

Received 5 February 2026

Published 24 March 2026

Request

I would like to see any and all information related to this study and it's endpoints specifically reduced behavioral reactivity and reproductive functional impairment. All email correspondence between regulators and stakeholders or discussion with regulators regarding clinical relevance. Here is the full study. Any information you have would be greatly appreciated. "Beck MJ. 2004. A study in young CD(IGS) rats administered fluoxetine hydrochloride (LY110140) orally by gavage to evaluate general, reproductive and behavioral toxicity, study. Document ID WIL-353039. Eli Lilly and Company. Peforming laboratory: WIL Research Laboratories."

Response

See attached

Documents

• FOI2026_00129 (redacted).pdf (928.2 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.